{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:07:17Z","timestamp":1789247237598,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011833","name":"Guangxi University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2025GXNSFBA069298"],"award-info":[{"award-number":["2025GXNSFBA069298"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tice.2026.103682","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:25:21Z","timestamp":1781461521000},"page":"103682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Qianlong Shutong Formula alleviates benign prostatic hyperplasia associated with the regulation of inflammation, fibrosis and the Hippo-YAP\/TAZ pathway"],"prefix":"10.1016","volume":"103","author":[{"given":"Ze-chao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-jin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-jie","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-feng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-tao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-sheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.tice.2026.103682_bib1","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.3390\/ijms24065904","article-title":"Alteration of gut microbes in benign prostatic hyperplasia model and finasteride treatment model","volume":"24","author":"An","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7320","key":"10.1016\/j.tice.2026.103682_bib2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/bmj.323.7320.1042","article-title":"Benign prostatic hyperplasia","volume":"323","author":"Barry","year":"2001","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.tice.2026.103682_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bju.15229","article-title":"Benign prostatic hyperplasia - what do we know?","volume":"127","author":"Devlin","year":"2021","journal-title":"BJU Int."},{"issue":"7","key":"10.1016\/j.tice.2026.103682_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","article-title":"Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine","volume":"19","author":"Dey","year":"2020","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.tice.2026.103682_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101122","article-title":"Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis","volume":"25","author":"Doridot","year":"2019","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.tice.2026.103682_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.tice.2026.103682_bib7","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/jgh.15987","article-title":"Extracellular vesicles produced by bone marrow mesenchymal stem cells overexpressing programmed death-ligand 1 ameliorate dextran sodium sulfate-induced ulcerative colitis in rats by regulating Th17\/Treg cell balance through PTEN\/PI3K\/AKT\/mTOR axis","volume":"37","author":"He","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.tice.2026.103682_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11325-022-02617-y","article-title":"Relationship between severity of obstructive sleep apnea and benign prostatic hyperplasia","volume":"27","author":"Huang","year":"2023","journal-title":"Sleep. Breath."},{"issue":"28","key":"10.1016\/j.tice.2026.103682_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000042957","article-title":"Review of Chinese medicine intervention in PI3K\/AKT pathway to regulate fibrosis","volume":"104","author":"Huang","year":"2025","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.tice.2026.103682_bib10","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.7150\/ijbs.77649","article-title":"Enhancement of Zyxin promotes skin fibrosis by regulating FAK\/PI3K\/AKT and TGF-\u03b2 signaling pathways via integrins","volume":"19","author":"Huang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"9","key":"10.1016\/j.tice.2026.103682_bib11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/iju.15518","article-title":"Chronic inflammation in benign prostatic hyperplasia: Pathophysiology and treatment options","volume":"31","author":"Inamura","year":"2024","journal-title":"Int. J. Urol."},{"issue":"13","key":"10.1016\/j.tice.2026.103682_bib12","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.3390\/ijms26136516","article-title":"Urinary inflammatory and oxidative stress biomarkers as indicators for the clinical management of benign prostatic hyperplasia","volume":"26","author":"Jiang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.tice.2026.103682_bib13","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bju.15286","article-title":"The rising worldwide impact of benign prostatic hyperplasia","volume":"127","author":"Launer","year":"2021","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.tice.2026.103682_bib14","first-page":"533","article-title":"Efficacy of Buzhong Yiqi decoction on benign prostatic hyperplasia and its possible mechanism","volume":"43","author":"Lihua","year":"2023","journal-title":"J. Tradit. Chin. Med."},{"issue":"5","key":"10.1016\/j.tice.2026.103682_bib15","article-title":"YAP1 recognizes inflammatory and mechanical cues to exacerbate benign prostatic hyperplasia via promoting cell survival and fibrosis","volume":"11","author":"Lin","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"5","key":"10.1016\/j.tice.2026.103682_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263291","article-title":"Based on network pharmacology and molecular docking to predict the mechanism of Huangqi in the treatment of castration-resistant prostate cancer","volume":"17","author":"Lin","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.tice.2026.103682_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2811789","article-title":"Targeting oxidative stress and endothelial dysfunction using tanshinone IIA for the treatment of tissue inflammation and fibrosis","volume":"2022","author":"Lu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.tice.2026.103682_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2018.03.042","article-title":"Hypoxia, oxidative stress and inflammation","volume":"125","author":"McGarry","year":"2018","journal-title":"Free. Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.tice.2026.103682_bib19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1186\/s12967-024-05604-x","article-title":"Correlation between benign prostatic hyperplasia and comorbidities: a systematic analysis integrating global burden of disease and mendelian randomization study","volume":"22","author":"Song","year":"2024","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.tice.2026.103682_bib20","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1111\/jcmm.16599","article-title":"Qianliexin capsule exerts anti-inflammatory activity in chronic non-bacterial prostatitis and benign prostatic hyperplasia via NF-\u03baB and inflammasome","volume":"25","author":"Zang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.tice.2026.103682_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s40520-023-02669-4","article-title":"The relationship between circulating metabolites and prostate hyperplasia: a Mendelian randomization study","volume":"36","author":"Zhang","year":"2024","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.tice.2026.103682_bib22","first-page":"1","article-title":"Exploring the efficacy of the traditional Chinese medicine compound formulas Qianlong Shutong formula in the treatment of benign prostatic hyperplasia","volume":"2","author":"Zhang","year":"2024","journal-title":"J. Mod. Pharmacol. Pathol."},{"issue":"4","key":"10.1016\/j.tice.2026.103682_bib23","first-page":"353","article-title":"Research progress in the relationship of hypoxia-inducible factor 1 with prostate diseases in hypoxic environment","volume":"29","author":"Zhang","year":"2023","journal-title":"Zhonghua Nan Ke Xue"},{"issue":"1","key":"10.1016\/j.tice.2026.103682_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12951-023-01788-4","article-title":"Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnology"},{"issue":"4","key":"10.1016\/j.tice.2026.103682_bib25","first-page":"3547","article-title":"PI3K\/Akt and HIF\u20111 signaling pathway in hypoxia\u2011ischemia (Review)","volume":"18","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.tice.2026.103682_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad518","article-title":"Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine","volume":"25","author":"Zhang","year":"2023","journal-title":"Brief. Bioinform"},{"key":"10.1016\/j.tice.2026.103682_bib27","doi-asserted-by":"crossref","DOI":"10.2174\/0113862073336172241220182220","article-title":"Verification of Qianlong Shutong formula in the treatment of benign prostatic hyperplasia","author":"Zhang","year":"2025","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"10.1016\/j.tice.2026.103682_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.intimp.2018.08.038","article-title":"Potential ameliorative effects of epigallocatechin\u20113\u2011gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats","volume":"64","author":"Zhou","year":"2018","journal-title":"Int. Immunopharmacol."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626003769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626003769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:20:32Z","timestamp":1789244432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626003769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"alternative-id":["S0040816626003769"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103682","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qianlong Shutong Formula alleviates benign prostatic hyperplasia associated with the regulation of inflammation, fibrosis and the Hippo-YAP\/TAZ pathway","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103682"}}